Health Technology Assessment

CPE Co-Authors Joint Stakeholder Statement on the First Joint Clinical Assessment Report

by miriah.conte@cancerpatientseurope.org
July 30, 2026July 30, 2026

CPE has joined a coalition focused on the advanced therapies and rare diseases, including patient organisations, clinicians, medical societies, academic centres and therapy developers, in endorsing a joint… Read More

CPE at the EAA Spring Convention: Co-Shaping the Future of the EU HTA Regulation

by secretariat
April 21, 2026

On 16–17 April 2026, CPE co-hosted the European Access Academy (EAA) Spring Convention in Brussels, alongside European Hematology Association (EHA). Centred on the implementation of the #EUHTA Regulation, the two-day… Read More

CPE at the World Evidence, Pricing and Access Congress: Advancing the Patient Voice in Rare Disease Access

by secretariat
March 3, 2026March 25, 2026

On 3 March 2026, CPE was at the World Evidence, Pricing and Access (EPA) Congress 2026 in Amsterdam, addressing the systemic barriers facing rare cancer patients across… Read More

CPE at the Cencora Webinar: Navigating Global Policy Shifts Through the Patient Lens

by secretariat
January 22, 2026February 17, 2026

On 22 January 2026, CPE took part in the Cencora webinar “Navigating global policy shifts: Implications for Europe’s pharmaceutical pricing, market access, and HTA landscape” to discuss how global… Read More

CPE at the EPF Webinar: One Year of HTA Regulation Implementation Through the Patient Lens

by secretariat
January 13, 2026October 13, 2026

On 13 January 2026, CPE took part in the European Patients’ Forum (EPF) webinar “One Year of HTA Regulation Implementation – What Has Changed for Patients?”, marking the first… Read More

CPE at the EHA Workshop: Ensuring Meaningful Patient Involvement in Joint European Clinical Assessments

by secretariat
November 26, 2025

On 21 November 2025, CPE participated in the European Huntington Association (EHA) Workshop “Access to Future Therapies – How Can We Ensure Patient Involvement in HTA Procedures… Read More

CPE at ISPOR Europe 2025: Embedding the Patient Voice in Health Technology Assessment and Research

by secretariat
November 18, 2025November 18, 2025

From 9–12 November 2025, CPE participated in ISPOR Europe 2025, held in Glasgow, Scotland. Under the theme “Powering Value and Access Through Patient-Centered Collaboration,” the conference explored how to strengthen partnerships across the… Read More

CPE at the EAA Fall Convention: Advancing Patient-Centred Evaluation in the EU HTA Framework

by secretariat
November 12, 2025

On 6–7 November 2025, CPE participated in the European Access Academy (EAA) Fall Convention, held at Université Paris Cité. The high-level event, titled “EU HTA – Procedural Insights & First Learnings”, focused… Read More

CPE at BEHEALTH 2025: Advancing Europe’s Beating Cancer Plan and Tackling Inequalities in Care

by secretariat
November 3, 2025

On 23 October 2025, CPE spoke at BEHEALTH 2025 in the panel “Europe’s Beating Cancer Plan: Strategies and Implementation”, part of the event’s focus on Digital Transformation in… Read More

CPE at the World Orphan Drug Congress Europe 2025: Ensuring Meaningful Patient Involvement in the JCA for ATMPs

by secretariat
October 30, 2025November 20, 2025

On 28 October 2025, CPE took part in the World Orphan Drug Congress Europe 2025 at the RAI Convention Centre in Amsterdam. The panel discussion, “How Will the JCA for… Read More